{"id":"W2949352054","doi":"10.1007/s12325-019-00994-7","title":"Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE)","year":2019,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Astellas Pharma Global Development; Astellas Pharma","keywords":"Mirabegron; Medicine; Overactive bladder; Quality of life (healthcare); Internal medicine; Adverse effect; Prospective cohort study; Discontinuation; Intensive care medicine; Urology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001085916,0.0002708381,0.0006879346,0.0002609708,0.0000314425,0.000009487941,0.00008361263,0.00006459395,0.0001510973],"category_scores_gemma":[0.00005164513,0.0001604129,0.00007374943,0.0004967404,0.00005910885,0.0003217158,0.00002398003,0.0001907093,0.000001392684],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006129261,"about_ca_system_score_gemma":0.0001504738,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006428116,"about_ca_topic_score_gemma":0.0004553649,"domain_scores_codex":[0.9981666,0.0001222058,0.0004248639,0.0004619533,0.0004617636,0.0003625849],"domain_scores_gemma":[0.9989376,0.0002190765,0.0002584317,0.0004087807,0.0001141252,0.00006196269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004418761,0.00642872,0.9767559,0.00002571543,0.000885261,0.0006008287,0.007175798,0.0000323909,0.001319322,0.00000111923,2.785462e-7,0.002355963],"study_design_scores_gemma":[0.01830591,0.0175224,0.9468507,0.0001250522,0.00002946141,0.0000130324,0.01306955,0.000007539631,0.003857842,0.00002755484,0.00002165163,0.0001692705],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956776,0.00101945,3.810508e-7,0.00003251967,0.00006953553,0.002692061,0.00001526376,0.00002401856,0.0004691672],"genre_scores_gemma":[0.9979724,0.001132185,0.00001090518,0.0000118379,0.000003951865,0.0001053323,0.00001759118,0.00003318332,0.0007126104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02990511,"threshold_uncertainty_score":0.6541449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04144466604187597,"score_gpt":0.3651091090916884,"score_spread":0.3236644430498124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}